The Participant Agreement for Contact Tracing (PACT) Study: Enhancing Partner Notification Services.
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00207493|
Recruitment Status : Completed
First Posted : September 21, 2005
Last Update Posted : September 27, 2012
|Condition or disease||Intervention/treatment||Phase|
|Chlamydia Infection Contact Tracing||Behavioral: Kit enhancement to referral Procedure: patient referral versus contract referral||Phase 1 Phase 2|
Patients diagnosed with chlamydial infections (a sexually transmitted disease) are asked to notify their sex partners and tell them to seek medical evaluation: patient referral. Rates of actual referral by patients are unknown, but estimates derived from several evaluations suggest somewhere between 30 - 55% of partners are notified and tested (for chlamydia). Current prevalence and yearly rates of infection suggest this level of partner notification and treatment is insufficient to control the disease.
As a program, this project has disseminated notification activities to community health centers that see chlamydial infections, all under the aegis of the awardee (Boston Medical Center). Diagnosis and partner notification can be recorded remotely , but centrally accessed through a secure database. To enhance patient referral effectiveness, this project tests brief instructions to refer (standard of care) against a "kit" containing a specific notification of exposure to chlamydia, an accurate health message about the nature and prognosis of the infection (treated and untreated), options for seeking free or low-cost evaluation and treatment, and a satisfaction survey. A second, crossed condition is pure patient referral against a contract (72 hours to notify, after which study staff will refer cases to public health professionals for notification).
Principal outcomes measured are levels of notification by participants of their partners and levels of reinfection among participants. We also measure psychosocial mediating effects, as well as potential unintended consequences of patient referral: incident partner violence against prevalent (baseline rates) violence, depressed affect
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||494 participants|
|Intervention Model:||Factorial Assignment|
|Official Title:||The Participant Agreement for Contact Tracing (PACT) Study: Enhancing Partner Notification Services.|
|Study Start Date :||October 2000|
|Primary Completion Date :||September 2005|
|Study Completion Date :||September 2007|
- 1. Participant reinfection rates
- 2. Participant notification rates
- 3. Proportion of partners seeking evaluation
- 1. Experience of violence attributable to notification
- 2. Relationship prognosis
- 3. Depression levels
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00207493
|United States, Massachusetts|
|Boston Medical Center|
|Boston, Massachusetts, United States, 02118|
|Principal Investigator:||Matthew Hogben, PhD||Centers for Disease Control and Prevention|
|Principal Investigator:||Guillermo Madico, PhD||Boston Medical Center|